Table of Contents Neurology.org/nn Online ISSN: 2332-7812 Volume 3, Number 2, April 2016 EDITOR’S CORNER e217 Alphabet soup J. Dalmau EDITORIAL e218 An older dog with newer tricks: Predicting efficacy of IFN-b treatment for multiple sclerosis G.F. Wu and E.E. Longbrake Companion article, e202 ARTICLES e202 Cytokine profiles show heterogeneity of interferon-b response in multiple sclerosis patients H. Hegen, I. Adrianto, C.J. Lessard, A. Millonig, A. Bertolotto, M. Comabella, G. Giovannoni, M. Guger, M. Hoelzl, M. Khalil, F. Fazekas, J. Killestein, R.L.P. Lindberg, S. Malucchi, M. Mehling, X. Montalban, D. Rudzki, F. Schautzer, F. Sellebjerg, P.S. Sorensen, F. Deisenhammer, L. Steinman, and R.C. Axtell Editorial, e218 e198 Visual dysfunction, but not retinal thinning, following anti-NMDA receptor encephalitis A.U. Brandt, T. Oberwahrenbrock, J. Mikolajczak, H. Zimmermann, H. Prüss, F. Paul, and C. Finke e200 Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis R. Bakshi, A. Yeste, B. Patel, S. Tauhid, S. Tummala, R. Rahbari, R. Chu, K. Regev, P. Kivisäkk, H.L. Weiner, and F.J. Quintana e210 Disrupted balance of T cells under natalizumab treatment in multiple sclerosis K. Kimura, M. Nakamura, W. Sato, T. Okamoto, M. Araki, Y. Lin, M. Murata, R. Takahashi, and T. Yamamura e204 Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis I. Metz, T. Beißbarth, D. Ellenberger, F. Pache, L. Stork, M. Ringelstein, O. Aktas, S. Jarius, B. Wildemann, H. Dihazi, T. Friede, W. Brück, K. Ruprecht, and F. Paul e207 Immunoadsorption therapy in autoimmune encephalitides M. Dogan Onugoren, K.S. Golombeck, C. Bien, M. Abu-Tair, M. Brand, M. Bulla-Hellwig, H. Lohmann, D. Münstermann, H. Pavenstädt, G. Thölking, R. Valentin, H. Wiendl, N. Melzer, and C.G. Bien e211 Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets S.K. Lundy, Q. Wu, Q. Wang, C.A. Dowling, S.H. Taitano, G. Mao, and Y. Mao-Draayer e213 Interleukin-7 treatment of PML in a patient with idiopathic lymphocytopenia D.P. Miskin, S.G. Chalkias, X. Dang, E. Bord, S. Batson, and I.J. Koralnik e209 The VZV/IE63-speci fic T cell response prevents herpes zoster in fingolimod-treated patients A. Mathias, G. Perriard, M. Canales, F. Vuilleumier, G. Perrotta, M. Schluep, and R. Du Pasquier e212 CNS accumulation of regulatory B cells is VLA-4-dependent K. Lehmann-Horn, S.A. Sagan, R.C. Winger, C.M. Spencer, C.C.A. Bernard, R.A. Sobel, and S.S. Zamvil ª 2016 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
Transcript
Table of ContentsNeurology.org/nn � Online ISSN: 2332-7812Volume 3, Number 2, April 2016
EDITOR’S CORNER
e217 Alphabet soupJ. Dalmau
EDITORIAL
e218 An older dog with newer tricks: Predicting efficacy ofIFN-b treatment for multiple sclerosisG.F. Wu and E.E. Longbrake
Companion article, e202
ARTICLES
e202 Cytokine profiles show heterogeneity ofinterferon-b response in multiple sclerosispatientsH. Hegen, I. Adrianto, C.J. Lessard, A. Millonig,A. Bertolotto, M. Comabella, G. Giovannoni, M. Guger,M. Hoelzl, M. Khalil, F. Fazekas, J. Killestein,R.L.P. Lindberg, S. Malucchi, M. Mehling,X. Montalban, D. Rudzki, F. Schautzer, F. Sellebjerg,P.S. Sorensen, F. Deisenhammer, L. Steinman, andR.C. Axtell
Editorial, e218
e198 Visual dysfunction, but not retinal thinning, followinganti-NMDA receptor encephalitisA.U. Brandt, T. Oberwahrenbrock, J. Mikolajczak,H. Zimmermann, H. Prüss, F. Paul, andC. Finke
e200 Serum lipid antibodies are associated with cerebraltissue damage in multiple sclerosisR. Bakshi, A. Yeste, B. Patel, S. Tauhid, S. Tummala,R. Rahbari, R. Chu, K. Regev, P. Kivisäkk, H.L. Weiner,and F.J. Quintana
e210 Disrupted balance of T cells under natalizumabtreatment in multiple sclerosisK. Kimura, M. Nakamura, W. Sato, T. Okamoto,M. Araki, Y. Lin, M. Murata, R. Takahashi, andT. Yamamura
e204 Serum peptide reactivities may distinguishneuromyelitis optica subgroups and multiplesclerosisI. Metz, T. Beißbarth, D. Ellenberger, F. Pache,L. Stork, M. Ringelstein, O. Aktas, S. Jarius,B. Wildemann, H. Dihazi, T. Friede, W. Brück,K. Ruprecht, and F. Paul
e207 Immunoadsorption therapy in autoimmuneencephalitidesM. Dogan Onugoren, K.S. Golombeck,C. Bien, M. Abu-Tair, M. Brand, M. Bulla-Hellwig,H. Lohmann, D. Münstermann, H. Pavenstädt,G. Thölking, R. Valentin, H. Wiendl, N. Melzer, andC.G. Bien
e211 Dimethyl fumarate treatment of relapsing-remittingmultiple sclerosis influences B-cell subsetsS.K. Lundy, Q. Wu, Q. Wang, C.A. Dowling,S.H. Taitano, G. Mao, and Y. Mao-Draayer
e213 Interleukin-7 treatment of PML in a patient withidiopathic lymphocytopeniaD.P. Miskin, S.G. Chalkias, X. Dang, E. Bord, S. Batson,and I.J. Koralnik
e209 The VZV/IE63-specific T cell responseprevents herpes zoster in fingolimod-treatedpatientsA. Mathias, G. Perriard, M. Canales,F. Vuilleumier, G. Perrotta, M. Schluep, andR. Du Pasquier
e212 CNS accumulation of regulatory B cells isVLA-4-dependentK. Lehmann-Horn, S.A. Sagan, R.C. Winger,C.M. Spencer, C.C.A. Bernard, R.A. Sobel, andS.S. Zamvil
ª 2016 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
e214 IL-17 production by CSF lymphocytes as a biomarkerfor cerebral vasculitisV. Thom, S. Schmid, M. Gelderblom,R. Hackbusch, M. Kolster, S. Schuster, G. Thomalla,O. Keminer, O. Pleß, C. Bernreuther, M. Glatzel,K. Wegscheider, C. Gerloff, T. Magnus, andE. Tolosa
CLINICAL/SCIENTIFIC NOTES
e203 Disseminated zoster with paresis in a multiple sclerosispatient treated with dimethyl fumarateB.B. Ma, L.W. Ostrow, and S.D. Newsome
e208 Failure of alemtuzumab as a rescue in a NMOSDpatient treated with rituximabM.C. Kowarik, M. Hoshi, B. Hemmer, and A. Berthele
e206 Degos disease mimicking primary vasculitis of the CNSS. Gmuca, M.D. Boos, A. Treece, S. Narula,L. Billinghurst, T. Bhatti, P. Laje, M.J. Perman,A. Vossough, B. Harding, J. Burnham, and B. Banwell
e215 Severe exacerbation of relapsing-remitting multiplesclerosis after G-CSF therapyH. Rust, J. Kuhle, L. Kappos, and T. Derfuss
e216 VZV in biopsy-positive and -negative giant cell arteritis:Analysis of 1001 temporal arteriesD. Gilden, T. White, N. Khmeleva, P.J. Boyer, andM.A. Nagel
Video LOE classification LOE recommendation Podcast
tinyurl.com/NeurologyNN twitter.com/GreenJournal
Cover image:High-power viewof skin showing increasedmucin arounddermal vessels, vesselwalls with smudged appearance, and 2 vessels filled with fibrin thrombi. See “Degos diseasemimicking primary vasculitis of the CNS.”
Table of Contentscontinued
ª 2016 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
Neurology.org/nn � Online ISSN: 2332-7812Volume 3, Number 2, April 2016
VISION: Neurology® Neuroimmunology & Neuroinflammation will bethe premier peer-reviewed journal for experts in the fields ofNeuroimmunology and Neuroinflammation.
MISSION: Neurology: Neuroimmunology & Neuroinflammation willprovide neurologists with peer-reviewed articles, editorials, andreviews to enhance patient care, education, and clinical &translational research.
EditorNeurology: Neuroimmunology & NeuroinflammationJosep O. Dalmau, MD, PhDICREA-University of BarcelonaBarcelona, SpainUniversity of PennsylvaniaPhiladelphia, PATel: 612-928-6400Toll-free: 800-957-3182 (US)Fax: [email protected]
Editor-in-ChiefNeurology®Robert A. Gross, MD, PhD, FAANProfessor of Neurology and of Pharmacology and PhysiologyStrong Epilepsy CenterUniversity of Rochester Medical CenterRochester, NYTel: 612-928-6400Toll-free: 800-957-3182 (US)Fax: [email protected]
Academy OfficersTerrence L. Cascino, MD, FAAN, PresidentRalph L. Sacco, MD, MS, FAAN, President ElectJames C. Stevens, MD, FAAN, Vice PresidentAaron E. Miller, MD, FAAN, SecretaryLisa M. Shulman, MD, FAAN, TreasurerTimothy A. Pedley, MD, FAAN, Past President
Executive Office, American Academy of NeurologyCatherine M. Rydell, CAE, Executive Director/CEO201 Chicago AveMinneapolis, MN 55415Tel: 612-928-6100
Editorial OfficePatricia K. Baskin, MS, Executive EditorKathleen M. Pieper, Managing Editor, NeurologySandra A. Moriarity, Senior Production EditorSharon L. Quimby, Managing Editor, Neurology® Clinical PracticeMorgan S. Sorenson, Managing Editor, Neurology: Neuroimmunology
& NeuroinflammationLee Ann Kleffman, Managing Editor, Neurology® GeneticsCynthia S. Abair, MA, Senior Graphics EditorRobert J. Witherow, Senior Editorial AssociateKaren Skaja, Senior Editorial AssociateAndrea R. Rahkola, Editorial AssociateKaitlyn Aman Ramm, Editorial AssistantKristen Swendsrud, Editorial Assistant
PublisherWolters KluwerBaltimore, MD
Publishing StaffKim Jansen, Executive PublisherAlexandra Lazerow, Production Team Leader, AAN JournalsKayla Bawroski, Production EditorNick Strickland, Production Associate
ª 2016 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
Neurology.org/nn � Online ISSN: 2332-7812Volume 3, Number 2, April 2016
EditorNeurology® Neuroimmunology & NeuroinflammationJosep O. Dalmau, MD, PhDICREA-University of BarcelonaBarcelona, SpainUniversity of PennsylvaniaPhiladelphia, PA
Editor-in-ChiefNeurology®Robert A. Gross, MD, PhD, FAANProfessor of Neurology and of Pharmacology and PhysiologyStrong Epilepsy CenterUniversity of Rochester Medical CenterRochester, NY
Deputy EditorsNeurologyBradford B. Worrall, MD, MSc, FAANProfessor of Neurology and Public Health SciencesUniversity of VirginiaCharlottesville, VA
Neurology: Neuroimmunology & NeuroinflammationScott S. Zamvil, MD, PhD, FAANDepartment of NeurologyUniversity of California, San FranciscoSan Francisco, CA
Lan Zhou, MD, PhDMount Sinai School of MedicineNew York, NYSpecialty: Neuromuscular
BiostatisticsRichard J. Kryscio, PhDUniversity of KentuckyLexington, KY
Christopher A. Beck, PhDUniversity of RochesterRochester, NY
Sue Leurgans, PhDRush University Medical CenterChicago, IL
Level of Evidence EvaluationsGary S. Gronseth, MD, FAANUniversity of KansasKansas City, KS
PodcastsTed M. Burns, MDUniversity of VirginiaCharlottesville, VA
Andrew M. Southerland, MD, MScUniversity of VirginiaCharlottesville, VA
OmbudsmanDavid A. Drachman, MD, FAANUniversity of Massachusetts Medical SchoolWorcester, MA
Scientific Integrity AdvisorRobert B. Daroff, MD, FAANCase Western Reserve UniversityCleveland, OH
Editorial BoardRohit Aggarwal, MD, MS, University of Pittsburgh, Pittsburgh, PASergio E. Baranzini, PhD, University of San Francisco, San Francisco, CASusanne Benseler, MD, Calgary, Alberta, CanadaJeffrey L. Bennett, MD, PhD, FAAN, University of Colorado, Aurora, COSéverine Boillée, PhD, Hôpital de la Salpêtriere, Paris, FranceMatthijs C. Brouwer, MD, PhD, Academic Medical Center, Amsterdam,The Netherlands
David B.Clifford,MD, FAAN,WashingtonUniversity School ofMedicine,St. Louis, MO
Russell C. Dale, MBChB, MRCP, PhD, University of Sydney, Sydney,Australia
Oscar H. Del Brutto, MD, FAAN, School of Medicine,Universidad Espiritu Santo, Samborondon, Ecuador
Thomas G. Forsthuber, MD, University of Texas, San Antonio, TXJoseph El Khoury, MD, Massachusetts General Hospital, Boston, MAMarkus P. Kummer, PhD, University of Bonn, Bonn, GermanyJun Li, MD, PhD, Vanderbilt University, Nashville, TNLin Mei, MD, PhD, Georgia Regents University, Augusta, GeorgiaChristopher Power, MD, University of Alberta, Alberta, CanadaRichard M. Ransohoff, MD, Biogen Idec, Boston, MAChristine Stadelmann, MD, University of Göttingen, Göttingen,Germany
Israel Steiner, MD, Rabin Medical Center, Petach Tikva, IsraelLawrence Steinman, MD, FAAN, Stanford University, Stanford, CAJesper Tegnér, PhD, MSc, Karolinska University Hospital, Stockholm,Sweden
SilviaN.Tenembaum,MD,NationalPediatricHospital, JuanP.Garrahan,Buenos Aires, Argentina
Maarten J. Titulaer, MD, PhD, Erasmus Medical Center, Rotterdam,The Netherlands
Ari Waisman, PhD, University of Mainz, Mainz, GermanyHugh J. Willison, MBBS, PhD, University of Glasgow, Glasgow, UKGregory F. Wu, MD, PhD, Washington University in St. Louis,St. Louis, MO
ª 2016 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
Neurology.org/nn � Online ISSN: 2332-7812Volume 3, Number 2, April 2016
Level of Evidence Review TeamMelissa J. Armstrong, MD, Gainesville, FLRichard L. Barbano, MD, PhD, FAAN, Rochester, NYRichard M. Dubinsky, MD, MPH, FAAN, Kansas City, KSJeffrey J. Fletcher, MD, MSc, Ann Arbor, MIGary M. Franklin, MD, MPH, FAAN, Seattle, WA
David S. Gloss II, MD, MPH&TM, Charleston, WVJohn J. Halperin, MD, FAAN, Summit, NJJason Lazarou, MSc, MD, Toronto, Ontario, CanadaSteven R. Messé, MD, FAAN, Philadelphia, PAPushpa Narayanaswami, MBBS, DM, FAAN, Boston, MAAlex Rae-Grant, MD, Cleveland, OH
Publication InformationNeurology® is a registered trademark of the American Academy of Neurology (registration valid in the United States).
Neurology® Neuroimmunology & Neuroinflammation is an official journal of the American Academy of Neurology.Journal website: Neurology.org/nn, AAN website: AAN.com
Translation Rights & Licensing queries: Silvia Serra, Global Director of Rights, Licensing, Permissions, Wolters Kluwer, [email protected].
Disclaimer:Opinions expressed by the authors and advertisers are not necessarily those of the American Academy of Neurology, its affiliates, orof the Publisher. The American Academy of Neurology, its affiliates, and the Publisher disclaim any liability to any party for the accuracy,completeness, efficacy, or availability of the material contained in this publication (including drug dosages) or for any damages arising out of theuse or non-use of any of the material contained in this publication.
Advertising Sales Representatives: Wolters Kluwer, 333 Seventh Avenue, New York, NY 10001. Contacts: Eileen Henry, tel: 732-778-2261, fax:973-215-2485, [email protected] and Valentin Torres, tel: 646-674-6354, cell: 646-628-4530, fax: 917-677-8420, [email protected]. In Europe: Avia Potashnik, Wolters Kluwer, tel: 144 207 981 0722; 144 7919 397 933 or e-mail: [email protected].
Careers & Events: Ryan Magee, Wolters Kluwer, Two Commerce Square, 2001 Market Street, Philadelphia, PA 19103, tel: 215-521-8804,fax: 215-521-8801; [email protected].
Special projects: US & Canada: Alan Moore, Wolters Kluwer, Two Commerce Square, 2001 Market Street, Philadelphia, PA 19103, tel:215-521-8638, [email protected]. International: Silvia Serra, Global Director of Rights, Licensing, Permissions, WoltersKluwer, [email protected].
ª 2016 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
http://nn.neurology.org/content/3/2.full.htmlincluding high resolution figures, can be found at:
Permissions & Licensing
http://nn.neurology.org/misc/about.xhtml#permissionsits entirety can be found online at:Information about reproducing this article in parts (figures,tables) or in
Reprints
http://nn.neurology.org/misc/addir.xhtml#reprintsusInformation about ordering reprints can be found online:
rights reserved. Online ISSN: 2332-7812.Published since April 2014, it is an open-access, online-only, continuous publication journal. Copyright . All
is an official journal of the American Academy of Neurology.Neurol Neuroimmunol Neuroinflamm
